June 2017

A new ribosomal biogenesis regulation point to treat cancer and 5q- syndrome

Leave a Comment / Metabolism and Cancer / By

Researchers in the Oncobell program at the Bellvitge Biomedical Research Institute (IDIBELL) – Catalan Institute of Oncology (ICO) have unveiled a new role for free 40S ribosomes as guardians of genetic information required to synthesize themselves. This mechanism, which relies on a complex of free 40S ribosomes and the RNA binding protein LARP1, is independent […]

A new ribosomal biogenesis regulation point to treat cancer and 5q- syndrome Read More »

Orgull en ciència: L’IDIBELL s’adhereix a la celebració del Dia per l’Alliberament LGTB+

Leave a Comment / Uncategorised / By

Per a commemorar aquesta diada l’IDIBELL i l’ICO han fet un vídeo per recordar algunes personalitats històriques del món de la ciència i la medicina que han estat pioneres en la lluita per a la igualtat de gènere i la diversitat. . Dia per l’Alliberament LGBTI La diada a Catalunya

Orgull en ciència: L’IDIBELL s’adhereix a la celebració del Dia per l’Alliberament LGTB+ Read More »

Facial paralysis image processing software is awarded a grant by the Academy of Medical Sciences

Leave a Comment / Uncategorised / By

Researchers from the Rehabilitation and Physiotherapy Department of Bellvitge University Hospital – Bellvitge Biomedical Research Institute (HUB-IDIBELL) have been awarded the VI basic research in physiotherapy grant from the Catalan-Balearic Physiotherapy Society, which will allow them to partially fund the clinical validation of a imaging software prototype designed as a facial neuromuscular therapy in patients

Facial paralysis image processing software is awarded a grant by the Academy of Medical Sciences Read More »

The complete epigenomes of the most frequent tumors, unveiled

Leave a Comment / Uncategorised / By

A research team from the Bellvitge Biomedical Research Institute (IDIBELL) has managed to characterize the complete epigenomes of the most frequent tumors, including those of colon, lung and breast cancer. Their work, published in Oncogene, was led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program at IDIBELL, ICREA Researcher and Professor

The complete epigenomes of the most frequent tumors, unveiled Read More »

Scroll to Top